Valuation : Raia Drogasil S.A.

Market Cap 34.95B 6.82B 5.87B 5.52B 5.05B 9.44B 645B 9.47B 65.25B 25.34B 330B 25.61B 25.06B 1,066B P/E 2026 *
23.7x
P/E 2027 * 17.5x
Enterprise Value 43.24B 8.44B 7.27B 6.83B 6.24B 11.68B 797B 11.72B 80.71B 31.35B 409B 31.68B 30.99B 1,318B EV / Sales 2026 *
0.95x
EV / Sales 2027 * 0.84x
Free-Float
73.24%
Yield 2026 *
1.83%
Yield 2027 * 2.15%
1 day+0.25%
1 week+3.25%
Current month+1.99%
1 month+2.99%
3 months+14.16%
6 months-18.51%
Current year-14.75%
1 week 19.42
Extreme 19.42
20.73
1 month 16.93
Extreme 16.93
20.73
Current year 16.21
Extreme 16.21
27.42
1 year 16.21
Extreme 16.21
27.42
3 years 12.81
Extreme 12.813725
29.8
5 years 12.81
Extreme 12.813725
29.8
10 years 10.42
Extreme 10.418549
29.8
Manager TitleAgeSince
Chief Executive Officer 50 2024-12-31
Director of Finance/CFO 63 2013-04-28
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman 50 2024-12-31
Director/Board Member - -
Director/Board Member - -
Date Insider Type Main position Quantity % Market Cap. Importance
5/29/26 Others -91,227 0.0052% -
5/28/26 Others -352,797 0.0201%
5/27/26 Others 351,489 0.0201%
Change 5-day change 1-year change 3-year change Capi.($)
+0.25%+3.25%+16.98%-26.23% 6.82B
-0.13%-1.46%-0.28%+32.49% 1.38B
+0.26%-9.73%+9.35%+19.49% 549M
+0.29%-0.04%-6.85%+28.15% 67.88M
Average +0.17%-2.00%+4.80%+13.48% 2.21B
Weighted average by Cap. +0.19%+1.68%+13.62%-13.76%

Financials

2026 *2027 *
Net sales 45.45B 8.87B 7.64B 7.18B 6.56B 12.28B 838B 12.32B 84.85B 32.96B 430B 33.31B 32.58B 1,386B 52B 10.15B 8.74B 8.21B 7.51B 14.04B 959B 14.09B 97.07B 37.7B 491B 38.11B 37.28B 1,586B
Net income 1.5B 293M 253M 237M 217M 406M 27.71B 407M 2.81B 1.09B 14.2B 1.1B 1.08B 45.82B 2.02B 394M 340M 319M 292M 546M 37.25B 547M 3.77B 1.46B 19.09B 1.48B 1.45B 61.59B
Net Debt 8.28B 1.62B 1.39B 1.31B 1.2B 2.24B 153B 2.24B 15.46B 6.01B 78.28B 6.07B 5.94B 253B 8.97B 1.75B 1.51B 1.42B 1.3B 2.42B 165B 2.43B 16.75B 6.51B 84.8B 6.58B 6.43B 274B
Logo Raia Drogasil S.A.
Raia Drogasil S.A. specializes in the distribution of medicines, cosmetics and dermocosmetics, perfumery, personal care and beauty products. Net sales break down by family of products as follows: - branded pharmaceuticals (42%); - pharmaceutical additives (25.1%) ; - OTC products (21.3%); - generic pharmaceutical products (11.4%). At the end of 2020, its products were marketed through a network of 2,299 pharmacies under the Drogasil (1,304) and Raia (995) brands in Brazil.
Employees
75,594
Date Price Change Volume
26-09-04 R$19.99 -1.38% 4,581,700
26-09-03 R$20.27 +0.25% 5,006,000
26-09-02 R$20.22 +2.85% 8,450,500
26-09-01 R$19.66 +0.31% 6,615,500
26-08-31 R$19.60 +1.24% 8,007,900
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
15
Last Close Price
19.99BRL
Average target price
25.25BRL
Spread / Average Target
+26.33%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. RADL3 Stock